The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nanomedicine-Global Market Insights and Sales Trends 2025
Synopsis
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
The global Nanomedicine market size is expected to reach US$ 246.8 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Nanomedicine in various end use industries. The expanding demands from the oncology, Infectious diseases, Cardiology and Orthopedics, are propelling Nanomedicine market. Quantum dots, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nanoparticles segment is estimated at % CAGR for the next seven-year period.
Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoparticles, nanomaterials, and nanodevices to deliver drugs, diagnose diseases, and monitor the health of patients at the molecular level.
Nanoparticles and nanomaterials can be engineered to have specific properties, such as size, shape, and surface chemistry, which allow for targeted and controlled delivery of drugs to specific cells or tissues in the body. This targeted drug delivery system increases the efficiency and effectiveness of treatments while minimizing side effects.
In addition to drug delivery, nanomedicine also includes the development of nanosensors and nanodevices for diagnostic purposes. These tiny devices can detect molecular markers of diseases, such as proteins or genetic material, at an early stage, enabling early intervention and personalized medicine. Nanosensors can also be used to monitor the health of patients in real-time, providing continuous data on various health parameters.
Nanomedicine has the potential to revolutionize healthcare by providing more precise and personalized treatments. It has the potential to improve drug efficacy, reduce drug toxicity, and enhance patient outcomes. However, there are still challenges that need to be addressed, such as the safety and toxicity of nanoparticles, as well as regulatory approval processes for nano-based medical products.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanomedicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanomedicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanomedicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanomedicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanomedicine covered in this report include Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck and Pfizer, etc.
The global Nanomedicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Global Nanomedicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanomedicine market, Segment by Type:
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Global Nanomedicine market, by Application
oncology
Infectious diseases
Cardiology
Orthopedics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanomedicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
The global Nanomedicine market size is expected to reach US$ 246.8 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Nanomedicine in various end use industries. The expanding demands from the oncology, Infectious diseases, Cardiology and Orthopedics, are propelling Nanomedicine market. Quantum dots, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nanoparticles segment is estimated at % CAGR for the next seven-year period.
Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoparticles, nanomaterials, and nanodevices to deliver drugs, diagnose diseases, and monitor the health of patients at the molecular level.
Nanoparticles and nanomaterials can be engineered to have specific properties, such as size, shape, and surface chemistry, which allow for targeted and controlled delivery of drugs to specific cells or tissues in the body. This targeted drug delivery system increases the efficiency and effectiveness of treatments while minimizing side effects.
In addition to drug delivery, nanomedicine also includes the development of nanosensors and nanodevices for diagnostic purposes. These tiny devices can detect molecular markers of diseases, such as proteins or genetic material, at an early stage, enabling early intervention and personalized medicine. Nanosensors can also be used to monitor the health of patients in real-time, providing continuous data on various health parameters.
Nanomedicine has the potential to revolutionize healthcare by providing more precise and personalized treatments. It has the potential to improve drug efficacy, reduce drug toxicity, and enhance patient outcomes. However, there are still challenges that need to be addressed, such as the safety and toxicity of nanoparticles, as well as regulatory approval processes for nano-based medical products.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanomedicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanomedicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanomedicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanomedicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanomedicine covered in this report include Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck and Pfizer, etc.
The global Nanomedicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Global Nanomedicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanomedicine market, Segment by Type:
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Global Nanomedicine market, by Application
oncology
Infectious diseases
Cardiology
Orthopedics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanomedicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nanomedicine
1.1 Nanomedicine Market Overview
1.1.1 Nanomedicine Product Scope
1.1.2 Nanomedicine Market Status and Outlook
1.2 Global Nanomedicine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanomedicine Market Size by Region (2018-2029)
1.4 Global Nanomedicine Historic Market Size by Region (2018-2023)
1.5 Global Nanomedicine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanomedicine Market Size (2018-2029)
1.6.1 North America Nanomedicine Market Size (2018-2029)
1.6.2 Europe Nanomedicine Market Size (2018-2029)
1.6.3 Asia-Pacific Nanomedicine Market Size (2018-2029)
1.6.4 Latin America Nanomedicine Market Size (2018-2029)
1.6.5 Middle East & Africa Nanomedicine Market Size (2018-2029)
2 Nanomedicine Market by Type
2.1 Introduction
2.1.1 Quantum dots
2.1.2 Nanoparticles
2.1.3 Nanoshells
2.1.4 Nanotubes
2.1.5 Nanodevices
2.2 Global Nanomedicine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanomedicine Historic Market Size by Type (2018-2023)
2.2.2 Global Nanomedicine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanomedicine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanomedicine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanomedicine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanomedicine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanomedicine Revenue Breakdown by Type (2018-2029)
3 Nanomedicine Market Overview by Application
3.1 Introduction
3.1.1 oncology
3.1.2 Infectious diseases
3.1.3 Cardiology
3.1.4 Orthopedics
3.1.5 Others
3.2 Global Nanomedicine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanomedicine Historic Market Size by Application (2018-2023)
3.2.2 Global Nanomedicine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanomedicine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanomedicine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanomedicine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanomedicine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanomedicine Revenue Breakdown by Application (2018-2029)
4 Nanomedicine Competition Analysis by Players
4.1 Global Nanomedicine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanomedicine as of 2022)
4.3 Date of Key Players Enter into Nanomedicine Market
4.4 Global Top Players Nanomedicine Headquarters and Area Served
4.5 Key Players Nanomedicine Product Solution and Service
4.6 Competitive Status
4.6.1 Nanomedicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Combimatrix
5.1.1 Combimatrix Profile
5.1.2 Combimatrix Main Business
5.1.3 Combimatrix Nanomedicine Products, Services and Solutions
5.1.4 Combimatrix Nanomedicine Revenue (US$ Million) & (2018-2023)
5.1.5 Combimatrix Recent Developments
5.2 Ablynx
5.2.1 Ablynx Profile
5.2.2 Ablynx Main Business
5.2.3 Ablynx Nanomedicine Products, Services and Solutions
5.2.4 Ablynx Nanomedicine Revenue (US$ Million) & (2018-2023)
5.2.5 Ablynx Recent Developments
5.3 Abraxis Bioscience
5.3.1 Abraxis Bioscience Profile
5.3.2 Abraxis Bioscience Main Business
5.3.3 Abraxis Bioscience Nanomedicine Products, Services and Solutions
5.3.4 Abraxis Bioscience Nanomedicine Revenue (US$ Million) & (2018-2023)
5.3.5 Celgene Recent Developments
5.4 Celgene
5.4.1 Celgene Profile
5.4.2 Celgene Main Business
5.4.3 Celgene Nanomedicine Products, Services and Solutions
5.4.4 Celgene Nanomedicine Revenue (US$ Million) & (2018-2023)
5.4.5 Celgene Recent Developments
5.5 Mallinckrodt
5.5.1 Mallinckrodt Profile
5.5.2 Mallinckrodt Main Business
5.5.3 Mallinckrodt Nanomedicine Products, Services and Solutions
5.5.4 Mallinckrodt Nanomedicine Revenue (US$ Million) & (2018-2023)
5.5.5 Mallinckrodt Recent Developments
5.6 Arrowhead Research
5.6.1 Arrowhead Research Profile
5.6.2 Arrowhead Research Main Business
5.6.3 Arrowhead Research Nanomedicine Products, Services and Solutions
5.6.4 Arrowhead Research Nanomedicine Revenue (US$ Million) & (2018-2023)
5.6.5 Arrowhead Research Recent Developments
5.7 GE Healthcare
5.7.1 GE Healthcare Profile
5.7.2 GE Healthcare Main Business
5.7.3 GE Healthcare Nanomedicine Products, Services and Solutions
5.7.4 GE Healthcare Nanomedicine Revenue (US$ Million) & (2018-2023)
5.7.5 GE Healthcare Recent Developments
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business
5.8.3 Merck Nanomedicine Products, Services and Solutions
5.8.4 Merck Nanomedicine Revenue (US$ Million) & (2018-2023)
5.8.5 Merck Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Nanomedicine Products, Services and Solutions
5.9.4 Pfizer Nanomedicine Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 Nanosphere
5.10.1 Nanosphere Profile
5.10.2 Nanosphere Main Business
5.10.3 Nanosphere Nanomedicine Products, Services and Solutions
5.10.4 Nanosphere Nanomedicine Revenue (US$ Million) & (2018-2023)
5.10.5 Nanosphere Recent Developments
5.11 Epeius Biotechnologies
5.11.1 Epeius Biotechnologies Profile
5.11.2 Epeius Biotechnologies Main Business
5.11.3 Epeius Biotechnologies Nanomedicine Products, Services and Solutions
5.11.4 Epeius Biotechnologies Nanomedicine Revenue (US$ Million) & (2018-2023)
5.11.5 Epeius Biotechnologies Recent Developments
5.12 Cytimmune Sciences
5.12.1 Cytimmune Sciences Profile
5.12.2 Cytimmune Sciences Main Business
5.12.3 Cytimmune Sciences Nanomedicine Products, Services and Solutions
5.12.4 Cytimmune Sciences Nanomedicine Revenue (US$ Million) & (2018-2023)
5.12.5 Cytimmune Sciences Recent Developments
5.13 Nanospectra Biosciences
5.13.1 Nanospectra Biosciences Profile
5.13.2 Nanospectra Biosciences Main Business
5.13.3 Nanospectra Biosciences Nanomedicine Products, Services and Solutions
5.13.4 Nanospectra Biosciences Nanomedicine Revenue (US$ Million) & (2018-2023)
5.13.5 Nanospectra Biosciences Recent Developments
6 North America
6.1 North America Nanomedicine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nanomedicine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanomedicine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanomedicine Market Dynamics
11.1 Nanomedicine Industry Trends
11.2 Nanomedicine Market Drivers
11.3 Nanomedicine Market Challenges
11.4 Nanomedicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
